Related Experiment Video
Updated: Jul 3, 2025
00:08
A Cross-Disciplinary and Multi-Modal Experimental Design for Studying Near-Real-Time Authentic Examination Experiences
Published on: September 4, 2019
7.0K
Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints.
Jan Meis1, Maximilian Pilz1, Björn Bokelmann2
1Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
Statistics in Medicine
|February 10, 2024
Summary
Adaptive trial designs present challenges for statistical analysis. This study summarizes methods to handle these complexities, comparing adaptive designs with group-sequential approaches for accurate estimation and P-value calculation.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Statistical Inference
Background:
- Adaptive trial designs introduce dependencies in sampling, complicating statistical estimation and P-value calculations.
- Optimal adaptive designs, while efficient, exacerbate these analytical challenges.
Purpose of the Study:
- To provide a comprehensive summary of existing analysis methods for adaptive trial designs.
- To demonstrate the application of these methods to planned adaptive designs, including optimal adaptive designs.
- To compare the performance of various estimators in optimal adaptive designs versus group-sequential designs.
Main Methods:
- Review and synthesis of statistical analysis methods for handling dependencies in adaptive trials.
- Application of these methods to a class of designs with prespecified adaptivity.
- Comparative analysis of estimator performance using optimal adaptive and group-sequential designs.
Main Results:
- Prespecified adaptive elements allow for explicit calculation descriptions, enabling fast and accurate method evaluation.
- An extensive comparison of performance characteristics between optimal adaptive and group-sequential designs is presented.
Conclusions:
- Established analysis methods can effectively address the complexities of planned adaptive trial designs.
- Understanding the performance differences between adaptive and group-sequential designs is crucial for optimal trial planning.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
01:15Assumptions of Survival Analysis
127
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
127
01:26Distributions to Estimate Population Parameter
4.1K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
4.1K
01:13Accuracy and Errors in Hypothesis Testing
199
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
199
01:20Actuarial Approach
78
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
78
01:24Kaplan-Meier Approach
138
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
138